The objective of this application is to obtain funds to open and maintain an animal facility for members of the Cancer Center. Such a facility is needed because infectious agents, and rodent viruses in particular, affect immune functions and animal survival in an uncontrollable manner; natural killer (NK) activity, macrophage functions, tumor resistance, and other immune responses in vivo can be drastically altered by infectious agents. Equally important is the fact that the establishment, growth, and function of T-cell lines in vitro can be drastically altered when """"""""filler cells"""""""" come from mice that have various subclinical infections. Furthermore, experiments testing (or depending upon) latency of virus infections can be seriously affected by intercurrent infections with other viruses. Finally, nude mice are essential for cancer research and must be bred and maintained in an environment that is free of pathogens. The plan is for a double-corridor animal facility with nine animal rooms containing a total of 28 """"""""Illinois cubicles."""""""" The design is based on the experience of other facilities. Because successful operation will depend entirely on very careful and knowledgeable supervision, the facility will be under the direction of a specially trained supervisor who has experience with the biology of rodent viruses and other important murine pathogens. The supervisor in consultations with the veterinarian, will oversee the microbiological testing and will strictly enforce and examine the effectiveness of the guidelines and procedures that must be followed by both the animal caretaker and the investigators using the facility. The high quality of the animal facility will increase the quality of the information obtained from animal experimentation. This in turn will (1) prevent many wasted experiments, (2) lead to more efficient use of research funds, and (3) reduce the number of animals that must be used in experiments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-16
Application #
3815817
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966
Sample, Ashley; Zhao, Baozhong; Wu, Chunli et al. (2018) The Autophagy Receptor Adaptor p62 is Up-regulated by UVA Radiation in Melanocytes and in Melanoma Cells. Photochem Photobiol 94:432-437
Hrusch, C L; Manns, S T; Bryazka, D et al. (2018) ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol 11:61-70

Showing the most recent 10 out of 668 publications